| MR-LC-ๅ้ | AstraZeneca | China | 2026-08-01 |
| MR-LC-่ๆน | AstraZeneca | China | 2026-08-01 |
| MR-GI-ๅไบฌ | AstraZeneca | China | 2026-08-01 |
| MR-GI-ๅไบฌ | AstraZeneca | China | 2026-08-01 |
| MR-GI-ๅนฟๅท | AstraZeneca | China | 2026-08-01 |
| MR-Hema-่ฅฟๅฎ | AstraZeneca | China | 2026-08-01 |
| MR-GI-ๆณๅท | AstraZeneca | China | 2026-08-01 |
| MR-Hema-ๅคฉๆดฅ | AstraZeneca | China | 2026-08-01 |
| MR-LC-ๆปจๅท | AstraZeneca | China | 2026-08-01 |
| Therapy Area Specialist / Pharmareferent (m/w/d) Respiratory; Gebiet: Mรผnster, Osnabrรผck, Oldenburg, Wilhelmshaven | AstraZeneca | United Kingdom | 2026-08-01 |
| Pharmaceutical Sales Specialist, Specialty Care -CVRM- Northern New England | AstraZeneca | United States | 2026-08-01 |
| R&I Primary Care District Sales Manager- Columbia, SC | AstraZeneca | United States | 2026-08-01 |
| AD-Commercial Analytics & Insights | AstraZeneca | China | 2026-08-01 |
| ARAM/RAM-RDU-้ๅบ | AstraZeneca | China | 2026-08-01 |
| MR-RSV-ๆ ๅท | AstraZeneca | China | 2026-08-01 |
| MR-Hema-ๅคฉๆดฅ | AstraZeneca | China | 2026-08-01 |
| MR-GI-ๆ้ฝ | AstraZeneca | China | 2026-08-01 |
| MR-RSV-ๆ ๅท | AstraZeneca | China | 2026-08-01 |
| MR-้พๅ-ๅไบฌ | AstraZeneca | China | 2026-08-01 |
| MR-้พๅ-ๆทฑๅณ | AstraZeneca | China | 2026-08-01 |
| Sr. Pharmaceutical Sales Specialist, Advanced Specialty Care-Respiratory Biologics, Boston North, MA | AstraZeneca | Boston, United States | 2026-08-01 |
| Therapy Area Specialist / Pharmareferent (m/w/d) Breast Cancer Oncology Gebiet: Brandenburg & Sachsen-Anhalt (Fokusregion Potsdam, Magdeburg und Lutherstadt Wittenberg) | AstraZeneca | United Kingdom | 2026-08-01 |
| BM/SBM-Tezspire MKT-ไธๆตท | AstraZeneca | China | 2026-08-01 |
| MR-BC-ๅไบฌ | AstraZeneca | China | 2026-08-01 |
| MR-CVRM-ๆธญๅ | AstraZeneca | China | 2026-08-01 |
| ARAM/RAM-RDU-้ฟๆฒ | AstraZeneca | China | 2026-08-01 |
| Key Account Manager Oncology (Lung cancer) Iasi | AstraZeneca | Bucharest, Romania | 2026-08-01 |
| MR-RSV-้้ณ | AstraZeneca | China | 2026-08-01 |
| SBM/BM-LC-ไธๆตท | AstraZeneca | China | 2026-08-01 |
| MR-CVRM-่ดต้ณ | AstraZeneca | China | 2026-08-01 |
| Primary Care Pharmaceutical Sales Specialist, R&I Garland, TX | AstraZeneca | United States | 2026-08-01 |
| Key Account Representative - Oncology | AstraZeneca | Panamรก, Panama | 2026-08-01 |
| Sr. Pharmaceutical Sales Specialist, CVRM Specialty-Albuquerque, NM | AstraZeneca | United Kingdom | 2026-08-01 |
| Pharmaceutical Sales Specialist, Respiratory Specialty Care - West Virginia | AstraZeneca | Charleston, United States | 2026-08-01 |
| Pharmaceutical Sales Specialist, CVRM Specialty โ Minneapolis, MN | AstraZeneca | United Kingdom | 2026-08-01 |
| DSM-RIN-่พฝๅฎ | AstraZeneca | China | 2026-08-01 |
| Strategic Business Development and Launch Excellence Lead | AstraZeneca | Petaling Jaya, Malaysia | 2026-08-01 |
| Pharmaceutical Sales Specialist, Respiratory Specialty Care - Chattanooga,TN | AstraZeneca | Chattanooga, United States | 2026-08-01 |
| Pharmaceutical Sales Specialist - R&I Primary Care - Anaheim, CA | AstraZeneca | United States | 2026-08-01 |
| Psychiatry Account Manager - Cleveland East, OH | H. Lundbeck A/S | Cleveland, United States | 2026-07-31 |
| Sales | Leo Pharma | Brazil | 2026-07-31 |
| Director, Commercial Data Management | Leo Pharma | Madison, United States | 2026-07-31 |
| Therapeutic Sales Specialist | Leo Pharma | Kansas City, United States | 2026-07-31 |
| ๅป่ฏไปฃ่กจ-็ๆฎ-ๆข
ๅท | Merck KGaA | Beijing, China | 2026-07-31 |
| Key Account Manager - Life Science | Merck KGaA | Nottingham, United Kingdom | 2026-07-31 |
| Account Manager_Process Solutions 1 | Merck KGaA | Mumbai, India | 2026-07-31 |
| Senior Commercial Project Manager - Upstream | Merck KGaA | Shanghai, China | 2026-07-31 |
| Key Account Sales Representative, Specialist | Organon | United States | 2026-07-31 |
| Representante de Ventas Sr. | Organon | Puebla, Mexico | 2026-07-31 |
| Representante de Vendas Jr - Sรฃo Josรฉ dos Campos | Organon | Bra, Italy | 2026-07-31 |